ASP9831

· Astellas Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP9831, covering 2013-03-21 to 2013-03-21. Get the full timeline:

Most recent: Clinical Trial Update: A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831 [Phase 2]

See pricing